Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMZS2XF)

Drug Name	FluNhance DMZS2XF
Synonyms	Influenza vaccine (rNA), Protein Sciences Corp; Influenza vaccine (recombinant neuraminidase), Protein Sciences Corp; RNeuraminidase based vaccine (influenza virus infection), Protein Sciences Corp

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Adenosine deaminase defciency	DISC2C93	4A01.1	Phase 3	[1]
------------------------------------------------------------------------------------

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Influenza virus infection	DISPWU75	1E30-1E32	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010156)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)